New Gpc Inc. Recalls Mustarcreme for Labeling and Listing Deficiencies
New Gpc Inc. is recalling Mustarcreme units in New York because the product lacks required drug listings, OTC labeling, and is marked not approved for U.S. sale.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves labeling and listing deficiencies rather than a direct physical hazard or reported illness, fitting the criteria for minor labeling errors or low-risk issues.
Plain-English summary
New Gpc Inc. has initiated a recall of Mustarcreme, a 60g (21 oz) over-the-counter drug product originating from Guyana. The recall involves 1,320 units distributed in New York. The affected batch numbers are 305150, 312236, and 311231.
The recall was issued because the product does not meet monograph requirements. Specifically, the product lacks a drug listing, fails to meet OTC drug labeling requirements, and is labeled as not approved for sale in the U.S.A.
Consumers who have purchased this product should stop using it and contact the recalling firm for further instructions.
The recalled product
- Product
- MUSTARCREME, Net Contents: 60g (21 oz) Country of Origin Guyana.
- Manufacturer
- New Gpc Inc.
- Category
- Drug — Over-the-Counter
- Affected units
- 1,320
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Batch Numbers: 305150
- 312236
- 311231
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 7 recalled by New Gpc Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · New Gpc Inc.
See all →- ModerateNew GPC Inc. Recalls Alcosulph Astringent Lotion for Labeling Deficiencies
FDA (Drugs) · 2014-10-29
- ModerateNew GPC Inc. Recalls Alcosulph Moisturizing Cream for Labeling Deficiencies
FDA (Drugs) · 2014-10-29
- ModerateNew Gpc Inc. Recalls Rector's Remedy Ointment for Labeling Deficiencies
FDA (Drugs) · 2014-10-29
- ModerateNew GPC Inc. Recalls Whitfield Lotion for Labeling Deficiencies
FDA (Drugs) · 2014-10-29
- ModerateNew GPC Inc. Recalls Ferrol Expectorant for Labeling Deficiencies
FDA (Drugs) · 2014-10-29
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateFDA Recalls Testosterone USP Micronized for Prescription Compounding
FDA (Drugs) · 2018-02-28
- ModerateProgesterone USP Recalled for Lack of Stability Data and Controls
FDA (Drugs) · 2018-02-28
- ModerateAmerican Pharmaceutical Ingredients Recalls Estrone USP Due to cGMP Deviations
FDA (Drugs) · 2017-06-21
- ModerateFDA Recalls Testosterone Enanthate USP Due to Missing Stability Data
FDA (Drugs) · 2018-02-28
- ModerateHydroquinone 4% Skin Bleaching Cream Recalled for Specification Failure
FDA (Drugs) · 2021-10-06
- ModerateGeritrex Recalls Unapproved Polyethylene Glycol 3350 Powder Jars
FDA (Drugs) · 2015-12-09